Overall, our results indicate that the regulatory effect of pelitinib on Twist1 is closely associated with the alterations in the expression levels of EMT-related genes and in the migratory and invasive properties of HCC. The gene discussed is TWIST1; the disease is hepatocellular carcinoma.